Multidisciplinary management of pediatric malignant rhabdoid tumor based on 5 years of experience at a tertiary care center

This retrospective study of 18 pediatric malignant rhabdoid tumor patients over 5 years demonstrates that complete surgical resection is the primary predictor of survival, with 3-year overall survival of 67%. Adjuvant chemotherapy and radiotherapy improved disease control rates, supporting a multimodal treatment approach for this rare and aggressive pediatric malignancy.